{
    "nctId": "NCT02495155",
    "briefTitle": "Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast Cancer",
    "officialTitle": "Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Fatigue, Insomnia, Pain",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 45,
    "primaryOutcomeMeasure": "Improvement in patient-reported symptom with use of PROSPECT for 8 weeks",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* Stage 0-III invasive carcinoma of the breast\n* Surgical resection and axillary assessment, radiation therapy, and/or chemotherapy, as indicated, completed at least 3 months prior to enrollment.\n* Concomitant trastuzumab and anti-endocrine therapies are permitted. If taking anti-endocrine therapy must have been taking for at least 3 months prior to enrollment.\n* Must report at least one of the following:\n\n  1. Fatigue in the week prior to enrollment at least 4 on a 10 point scale (with 0 = not tired at all and 10 = extremely tired)\n  2. Insomnia in the week prior to enrollment\n  3. Pain in the week prior to enrollment at least 4 on a 10 point scale (with 0 = no pain and 10 = extremely severe pain)\n* Has access to and is able to operate a computer with internet access.\n* Able to read and understand English.\n* Willing and able to sign an informed consent document.\n\nExclusion Criteria:\n\n- Diagnosis of sleep apnea or restless leg syndrome that is currently interfering with sleep",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}